JO
BPMC

John Overdeck’s Blueprint Medicines BPMC Stock Holding History

John Overdeck’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,800
Closed -$576K – 3021
2023
Q1 		$576K Sell
12,800
-32,909
-72% -$1.48M ﹤0.01% 2142
2022
Q4 		$2M Sell
45,709
-63,526
-58% -$3.05M 0.01% 1318
2022
Q3 		$7.2M Buy
109,235
+98,522
+920% +$6.33M 0.02% 616
2022
Q2 		$541K Buy
+10,713
New +$628K ﹤0.01% 1796
2020
Q1 		– Sell
-43,318
Closed -$3.47M – 3133
2019
Q4 		$3.47M Sell
43,318
-75,052
-63% -$5.62M 0.01% 1190
2019
Q3 		$8.7M Sell
118,370
-98,156
-45% -$8.48M 0.03% 597
2019
Q2 		$20.4M Buy
216,526
+118,313
+120% +$9.77M 0.07% 345
2019
Q1 		$7.86M Sell
98,213
-111,653
-53% -$8.25M 0.03% 762
2018
Q4 		$11.3M Buy
209,866
+96,007
+84% +$5.84M 0.04% 505
2018
Q3 		$8.89M Sell
113,859
-233,979
-67% -$16.3M 0.02% 692
2018
Q2 		$22.1M Buy
347,838
+272,350
+361% +$21.7M 0.07% 380
2018
Q1 		$6.92M Buy
75,488
+25,278
+50% +$2.18M 0.02% 770
2017
Q4 		$3.79M Sell
50,210
-60,483
-55% -$4.26M 0.01% 1042
2017
Q3 		$7.71M Buy
110,693
+47,216
+74% +$2.52M 0.03% 618
2017
Q2 		$3.22M Sell
63,477
-84,628
-57% -$3.59M 0.01% 1112
2017
Q1 		$5.92M Buy
+148,105
New +$5.3M 0.02% 849
2016
Q4 		– Sell
-9,700
Closed -$288K – 3105
2016
Q3 		$288K Buy
+9,700
New +$241K ﹤0.01% 2769

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

John Overdeck's BPMC Position: Q2 2023 in Review

John Overdeck sold out of Blueprint Medicines (BPMC) in Q2 2023, closing a stake of 12,800 shares — an estimated $576K sold.

John Overdeck first reported a position in BPMC in Q3 2016 and held it in 17 quarters. The position peaked at $22.1M in Q2 2018. 222 funds tracked by Wall St. Rank hold BPMC as of Q2 2023.

  • John Overdeck reported no remaining Blueprint Medicines position as of Q2 2023 after selling out during the quarter.
  • John Overdeck sold 12,800 Blueprint Medicines shares in Q2 2023, an estimated $576K.
  • John Overdeck first reported a position in Blueprint Medicines in Q3 2016 and held it in 17 quarters.
  • John Overdeck's Blueprint Medicines position peaked at $22.1M in Q2 2018.
  • 222 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.